Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.

about

Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.

Item

http://www.wikidata.org/entity/Q40289330

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cell-based immunotherapy with ...... sting to clinical application.

@en

type

Item

label

Cell-based immunotherapy with ...... sting to clinical application.

@en

prefLabel

Cell-based immunotherapy with ...... sting to clinical application.

@en

P1476

Cell-based immunotherapy with ...... sting to clinical application.

@en

P2093

Fanjuan Meng

http://www.w3.org/2001/XMLSchema#string

Guirong Zhang

http://www.w3.org/2001/XMLSchema#string

Nan Su

http://www.w3.org/2001/XMLSchema#string

Shi Chen

http://www.w3.org/2001/XMLSchema#string

Sulan Sun

http://www.w3.org/2001/XMLSchema#string

Tianzhao Du

http://www.w3.org/2001/XMLSchema#string

Xiaoxi Li

http://www.w3.org/2001/XMLSchema#string

Yefeng Wu

http://www.w3.org/2001/XMLSchema#string

Yiming Meng

http://www.w3.org/2001/XMLSchema#string

Yushu Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced health biotechnologies in Thailand: redefining policy directions

Immune response, safety, and survival and quality of life outcomes for advanced colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell therapy

Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells

Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects

Telomerase Regulation from Beginning to the End

Regulation of cutaneous malignancy by gammadelta T cells

Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer

Multivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer cells.

Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1285987

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28301281

http://www.w3.org/2001/XMLSchema#string

P932

5489295

http://www.w3.org/2001/XMLSchema#string